Brazil approves Pfizer's coronavirus vaccine, but has none to use

Brazil has fully approved the COVID-19 vaccine developed by Pfizer Inc and BioNTech SE , its health regulator said on Tuesday, though a dispute over a supply deal means it has none to start an immunization program with.
 

It is the first coronavirus shot to receive full approval in Brazil, regulator Anvisa said. Vaccines developed by AstraZeneca and China's Sinovac Biotech Ltd, have only been approved for emergency use.
 

The approval is good news for a country whose immunization campaign has been plagued by delays and political squabbling.

However, it is unclear whether this will pave the way for a supply